Literature DB >> 3891920

Hyperbaric oxygen in chronic progressive multiple sclerosis: visual evoked potentials and clinical effects.

J Neiman, B Y Nilsson, P O Barr, D J Perrins.   

Abstract

The effects of hyperbaric oxygen at a pressure of two atmospheres absolute were studied in a group of patients with chronic progressive multiple sclerosis. A slight but statistically insignificant shortening of the visual evoked potential latencies was seen after treatment with hyperbaric oxygen as compared with placebo treatment. The treatment did not appreciably halt the progression of the disease and deferioration occurred more often among the patients in the treatment group than in the control group.

Entities:  

Mesh:

Year:  1985        PMID: 3891920      PMCID: PMC1028364          DOI: 10.1136/jnnp.48.6.497

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  19 in total

1.  Critique of experimental trials of therapy in multiple sclerosis.

Authors:  G A Schumacher
Journal:  Neurology       Date:  1974-11       Impact factor: 9.910

2.  [Use of hyperbaric oxygen in various neurologic diseases. (Preliminary report)].

Authors:  V Boschetty; J Cernoch
Journal:  Bratisl Lek Listy       Date:  1970-03       Impact factor: 1.278

3.  Immunoglobulin G and low molecular weight proteins in human cerebrospinal fluid. Chemical and immunological characterisation with special reference to multiple sclerosis.

Authors:  H Link
Journal:  Acta Neurol Scand       Date:  1967       Impact factor: 3.209

4.  Visual evoked response in diagnosis of multiple sclerosis.

Authors:  A M Halliday; W I McDonald; J Mushin
Journal:  Br Med J       Date:  1973-12-15

5.  Serial recording of visual and somatosensory evoked potentials in multiple sclerosis.

Authors:  W B Matthews; D G Small
Journal:  J Neurol Sci       Date:  1979-01       Impact factor: 3.181

6.  Visual evoked responses in multiple sclerosis: comparison of two methods for pattern reversal.

Authors:  B Y Nilsson
Journal:  J Neurol Neurosurg Psychiatry       Date:  1978-06       Impact factor: 10.154

7.  Problems in evaluating new treatments for multiple sclerosis.

Authors:  J R Brown
Journal:  Neurology       Date:  1980-07       Impact factor: 9.910

8.  Exposure of multiple sclerosis patients to hyperbaric oxygen at 1.5--2 ATA. A preliminary report.

Authors:  R A Neubauer
Journal:  J Fla Med Assoc       Date:  1980-05

9.  Oxygen immunosuppression: modification of experimental allergic encephalomyelitis in rodents.

Authors:  J Warren; M R Sacksteder; C A Thuning
Journal:  J Immunol       Date:  1978-07       Impact factor: 5.422

10.  Ameliorating effects of hyperbaric oxygenation on experimental allergic encephalomyelitis.

Authors:  L D Prockop; R J Grasso
Journal:  Brain Res Bull       Date:  1978 May-Jun       Impact factor: 4.077

View more
  4 in total

1.  Hyperbaric oxygen in multiple sclerosis: discussion paper.

Authors:  D Bates
Journal:  J R Soc Med       Date:  1986-09       Impact factor: 5.344

2.  Hyperbaric oxygen and multiple sclerosis: final results of a placebo-controlled, double-blind trial.

Authors:  M P Barnes; D Bates; N E Cartlidge; J M French; D A Shaw
Journal:  J Neurol Neurosurg Psychiatry       Date:  1987-11       Impact factor: 10.154

Review 3.  A review on the neuroprotective effects of hyperbaric oxygen therapy.

Authors:  Fahimeh Ahmadi; Ali Reza Khalatbary
Journal:  Med Gas Res       Date:  2021 Apr-Jun

Review 4.  Double-blind trials in hyperbaric medicine: A narrative review on past experiences and considerations in designing sham hyperbaric treatment.

Authors:  C A Lansdorp; Rob A van Hulst
Journal:  Clin Trials       Date:  2018-06-04       Impact factor: 2.486

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.